SEC Form 4 · accession 0001493152-26-028132
OKYO Pharma Ltd · OKYO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willy Jules Simon
Director
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001849296
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option | $1.85 | Jun 8, 2026 | A | 6,500 | A | Jun 8, 2027 | Jun 8, 2036 | Common Shares | 6,500 | 135,502 | D |
Remarks
Options vest 25% per year over four years beginning on the first anniversary of the grant date